AMGEN INC is 112.6x more valuable than aTYR PHARMA INC by market capitalization ($182.28 B vs $1.62 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LIFE | AMGN |
|---|---|---|
| Market cap | $1.62 B | $182.28 B |
| US-listed rank | #2252 | #80 |
| Revenue (latest FY) | $190.00K | $36.75B |
| Net income (latest FY) | -$74.12M | $7.71B |
| Net margin | -39009.5% | 21.0% |
| P/E (trailing FY) | - | 23.6 |
| SEC filings | 720 | 1,011 |
AMGEN INC is 112.6x more valuable than aTYR PHARMA INC by market capitalization ($182.28 B vs $1.62 B).
In their latest fiscal years, aTYR PHARMA INC reported $190.00K in revenue while AMGEN INC reported $36.75B.
Full pages: aTYR PHARMA INC and AMGEN INC, or browse the full rankings.